You searched for "vascular"

1063 results found

Blind Football Fan ‘Scores’ Support

A Ross County supporter has praised the club and leading sight loss charity, RNIB Scotland, for helping him to keep attending games.

In conversation with Vasuki Sivagnanavel at 100% Optical

At 100% Optical at the end of February, we were lucky enough to run into Vasuki Sivagnanavel, Consultant Ophthalmic Surgeon at The Royal Eye Unit, Kingston Hospital, shortly after her presentation: 'Diagnostic insights with retinal ultra-widefield multimodal imaging - perspectives from an optometrist and ophthalmologist'.

Humanitarian aid for World Optometry Day

Lions Clubs International, a charity dedicated to providing humanitarian aid across the world, is thanking SpaMedica hospitals for their support with improving global eye health this World Optometry Day. World Optometry Day took place on Sunday 23rd March, with the...

A Shared Vision: national clinical director outlines plan for eye care transformation

This session will explore how nationally coordinated eye care can deliver improvements to patient outcomes, what should be the priorities and where responsibility for policy delivery sits across the NHS architecture. Attendees will have the opportunity to both learn more about NHS England’s ongoing work to support improvements to eye care and input into that process.

Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service

The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...

The evolution and visual prognosis of glial proliferation of different grades after macular hole surgery

This retrospective research study aimed to investigate the evolution of glial proliferation of varying grades after successful idiopathic macular hole repair and its effects on foveal microstructure and best-corrected visual acuity (BCVA). Two-hundred and two eyes were enrolled in this...

Intravitreal Aflibercept (IVT-AFL): treatment of macular oedema secondary to RVO

This paper is a sub-group analysis of the real-world effectiveness, treatment patterns, and safety of IVT-AFL in patients with macular oedema secondary to retinal vein occlusion (RVO) in Italy. One hundred and fifity-two treatment-naïve and 50 pretreated patients were enrolled...

UKEGS (UK and Éire Glaucoma Society) Conference 2024

Pretty soon it’s going to be the 9th of October, and a quick Wikipedia search will tell you of how this day in history has seen the founding of the Kingdom of Valencia, the initial whispers of the Prague Astronomical...

Treat-and-extend regimen in treatment of patients with type 3 neovascularisation

Type 3 neovascularisation, also known as retinal angiomatous proliferation is a distinct subtype of neovascular AMD characterised by intraretinal neovascularisation. This retrospective study included 17 eyes diagnosed with type 3 neovascularisation who were changed from pro-re-nata (PRN) based treatment regime...

NEOS (North Of England Ophthalmological Society) Spring Meeting 2024

by Matthew Hartley, Trainee, Northern Deanery, UK. In NEOS’ 110th year, the spring meeting was held in Doncaster and centred around ocular oncology and vitreoretinal surgery. The meeting hosts, Umi Harley and Steve Winder from Royal Hallamshire Hospital, arranged a...

Moorfields Education: Fundoscopy training programme

Fundoscopy training programmeThis new training programme has been designed to develop knowledge and skill in fundus biomicroscopy assessment using relevant diagnostic lenses. The programme will support learners to expand their clinical role in a variety of sub-specialist Ophthalmic settings. It...

Moorfields: The 2025 macula course

The 2025 Macula course will take place from 2nd - 5th June 2025. Bookings are now open. Retinal diseases are a major cause of blindness. Diagnostic investigations, understanding of disease mechanisms, new therapies, and the evidence base, have all evolved...